The three patients who relapsed after month 6 were all retreated with a second course of rituximab leading to sustained remission lasting more than 6 months in all three. an estimated 130 million people (1). Up to 20% of individuals with chronic HCV illness will develop potentially fatal complications such as cirrhosis, liver failure, or […]